Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab
JAAD Case Rep
.
2024 Feb 18:46:95-99.
doi: 10.1016/j.jdcr.2024.02.007.
eCollection 2024 Apr.
Authors
Kalisa Lum
1
,
Ruth Sanchez
2
,
Cici Zhou
3
,
Sophia Sangar
3
,
Harry Dao Jr
3
,
Ashley Elsensohn
3
4
Affiliations
1
School of Medicine, Loma Linda University Health, Loma Linda, California.
2
School of Medicine, California University of Science and Medicine, Colton, California.
3
Department of Dermatology, Loma Linda University Health, Loma Linda, California.
4
Department of Pathology and Human Anatomy, Loma Linda University Health, Loma Linda, California.
PMID:
38577499
PMCID:
PMC10990732
DOI:
10.1016/j.jdcr.2024.02.007
No abstract available
Keywords:
African American; B-cell pseudolymphoma; Type V skin; dupilumab; therapy.
Publication types
Case Reports